New targeted therapy shows potential for previously treated metastatic kidney cancer
A phase II study published in Frontiers in Oncology last [...]
ASCO 2020: Implications of the research presented at ASCO 2020 on the treatment of advanced kidney cancer
In this video presentation, Dr Toni Chouieri discusses the SAVOIR, [...]
The effect of age and gender on outcomes in kidney cancer
In this interview, Dr Rana McKay discusses the impact of [...]
Combination immunotherapy plus VEGFR inhibitor for favourable risk and elderly kidney cancer patients
A study published in Clinical Genitourinary Cancer this month looks [...]
COVID-19 outcomes in patient with cancer on anti-cancer treatments
Back in March at the start of the COVID-19 pandemic [...]
Bone metastases are associated with poor prognosis in papillary kidney cancer
A recent retrospective study looked at the data from 49 [...]
Atezolizumab alone or in combination with bevacizumab for untreated metastatic kidney cancer
This paper reports patient-reported outcomes from the phase 2 IMmotion150 [...]
ASCO GU 2020: Nephrectomy linked to longer overall survival in patients treated with immunotherapy or targeted therapy for advanced kidney cancer
Surgery to remove the kidney tumour is often the preferred [...]
The effect of weight change on kidney cancer patients treated with targeted therapy
A recent retrospective study of 3311 patients with metastatic renal [...]
Major updates in the management of metastatic kidney cancer
In this video interview, Dr Eric Jonasch from MD Anderson [...]
